Adam J. Townsend, Chief Commercial Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 5,000 shares at $63.84 ($319K) on 2023-03-03, disclosed to the SEC on 2023-03-07.
Open-market sale of $319k APLS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APLS | SELL | 2025-01-21 | $132K | — | Filing → |
| APLS | SELL | 2025-01-14 | $154K | — | Filing → |
| APLS | SELL | 2024-02-13 | $156K | — | Filing → |